Rapid progression (n = 54) Slow progression (n = 55) p Age at examination (years) 14.6 ± 7.5 16.5 ± 5.1 NS (0.7–24.0) (7.3–25.0) NS Age at CKD diagnosis (years) 9.9 ± 6.8 5.6 ± 6.1 0.001 (0.01–22.0) (0.1–20.0) Etiology of…
Sarcoidosis Controls p (n = 111) (n = 65) Age (years) 44.8 ± 10.4 43.3 ± 12.4 BMI (kg/m2) 28.2 ± 3.9 26.8 ± 5.6 0.091 FAS 22.9 ± 7.9 17.0 ± 3.3 0.046 MRC 1.3 ± 0.8 1.1 ± 0.3 0.028 OCD 1.6 ± 0.8 1.1 ± 0.3 0.025 Borg’s scale 0.7 ± 1.3…
© Springer International Publishing Switzerland 2014Mieczyslaw Pokorski (ed.)Lung Cancer and Autoimmune DisordersAdvances in Experimental Medicine and Biology83310.1007/5584_2014_17 The Potential of Wharton’s Jelly Derived Mesenchymal Stem Cells in Treating Patients with Cystic Fibrosis D. Boruczkowski1 ,…
Patients rs1800734 Patients rs2303425 Controls rs1800734 Control rs2303425 Total sample (n) 422 422 511 486 Gender Male n (%) 322 (76) 324 (77) 287 (56) 270 (56) Female n…
Fig. 7.1. Axial CT view of an image-guided IMRT plan for cervical cancer. Image courtesy of C. Yashar. Fig. 7.2. Coronal CT view of an image-guided IMRT plan for vulvar…
Fig. 8.1. Airway pressure curve at the end of inspiration and held expiration. Initial decrease in peak pressure followed by the plateau pressure. An acute change in upper airway resistance…
Fig. 5.1. (a) Complete hydatidiform mole. All chorionic villi are enlarged and have abnormal shapes. There is marked hyperplasia of the trophoblast. Circumferential proliferation of the trophoblast around the villi…
Opioid Dosage form Strength Starting doses of short-acting opioids for opioid naïve patients Morphine Oral solution Tablets ER (q12 h) Tablets ER (q 24 h) Tablets IR Injectable SC, IV,…
Fig. 3.1. Histolopathologic Types of Carcinoma of the Vulva: SEER Data 1988–2001 [2]. Data source: Kosary CL. Cancer of the Vulva. In: Ries LAG, Young JL, Keel GE, Eisner MP,…
E1 E2 E4 E5 E6 E7 L1 L2 ATPase Regulator of E6 and E7 Disrupts cytokeratin matrix for release of virions Potentiation of membrane bound EGF receptors Bind and inactivate…
